Drawing for ARNA

USPTO serial 79254562

ARNA

Reviewed by CopyMark Law Group

Reg. 6495437Status 700Renewal
Filing date
Status date
Registration date
Sep 28, 2021
Examiner
SPILS, CAROL A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ARNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHAEL SHARIFF

MICHAEL SHARIFF INVENTA CAPITAL GROUP PLC1010 PARKWAY TRLBLOOMFIELD HILLS, MI 48302UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Blood for medical purposes for use in genetic testing of oncology diseases; Blood for medical purposes for use in proteins activities testing in oncology diseases; blood plasma for use in genetic testing of oncology diseases; blood plasma for use in protein activities testing in oncology diseases; diagnostic preparations for medical purposes for use in genetic testing of oncology diseases; diagnostic preparations for medical purposes for use in proteins activities testing of oncology diseases; biological tissue cultures for medical purposes for use in genetic testing of oncology diseases; biological tissue culture for medical purposes for use in proteins activities testing in oncology diseasesACTIVE—
010Blood testing apparatus; Blood testing apparatus for medical purposes; apparatus for DNA and RNA testing for medical purposesACTIVE—
042Scientific and technological services, namely, research and design in the field of diagnostic methods for genetic testing of oncology diseases; scientific and technological services, namely, research and design in the field of diagnostic methods for use in proteins activities testing in oncology diseases; design and development of computer hardware and software in the field of robotization within the medical and biotechnological fields; design and development of computer software in the field of data analysis for medical and biotechnological applications; scientific laboratory services for use in genetic testing of oncology diseases; scientific laboratory services for use in proteins activities testing in oncology diseasesACTIVE—
044Medical services; health counselling; medical clinic servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 28, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 4, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 14, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 14, 2022FIMPFINAL DISPOSITION PROCESSED—
Dec 28, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 28, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 23, 2021TMBNTTAB RELEASE CASE TO TRADEMARKS—
Aug 23, 2021OP.TOPPOSITION TERMINATED NO. 999999—
Aug 23, 2021OP.DOPPOSITION DISMISSED NO. 999999—
Jun 8, 2021OP.TOPPOSITION TERMINATED NO. 999999—
Jun 8, 2021OP.DOPPOSITION DISMISSED NO. 999999—
Apr 24, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 7, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 7, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 23, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 19, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 19, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 19, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 19, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 19, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 19, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 7, 2020RFNPREFUSAL PROCESSED BY IB—
Feb 21, 2020OP.IOPPOSITION INSTITUTED NO. 999999—
Feb 12, 2020OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Feb 12, 2020OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Jan 24, 2020RFNPREFUSAL PROCESSED BY IB—
Jan 10, 2020OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 20, 2019OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Dec 20, 2019OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Dec 12, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 16, 2019GPNXNOTIFICATION PROCESSED BY IB—
Nov 8, 2019CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 1, 2019CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 30, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 30, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 30, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 11, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 11, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Oct 11, 2019ALIEASSIGNED TO LIE—
Oct 11, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 11, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 11, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 24, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 10, 2019RFNTREFUSAL PROCESSED BY IB—
Apr 24, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 24, 2019RFRRREFUSAL PROCESSED BY MPU—
Apr 3, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 2, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 25, 2019DOCKASSIGNED TO EXAMINER—
Mar 25, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 21, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance